Literature DB >> 11466028

Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS).

J C Möller1, H M Hamer, W H Oertel, F Rosenow.   

Abstract

The aim of this paper is to report a patient with late-onset myoclonic epilepsy in Down's syndrome (LOMEDS) as a differential diagnosis of adult-onset progressive myoclonic epilepsies. A 55-year-old male with Down's syndrome (DS) is described who developed progressively frequent myoclonus and generalized myoclonic-tonic seizures (GMTSs) at the age of 52. EEG recordings demonstrated background slowing and generalized polyspike-wave discharges occasionally associated with myoclonic jerks, leading to the classification of primary generalized epileptic myoclonus. Descriptions of late-onset epilepsy in DS patients are rare. However, a review of the pertinent literature revealed at least two other cases of elderly DS patients developing progressive myoclonic epilepsy after the onset of dementia. We suggest that late-onset myoclonic epilepsy in Down's syndrome as characterized here should be considered in the differential diagnosis of adult-onset myoclonic epilepsies. LOMEDS apparently shares features with myoclonic epilepsy in Alzheimer's disease (AD) and Unverricht-Lundborg disease (ULD) caused by a mutation on chromosome 21. Since life expectation of DS patients has markedly increased, LOMEDS may be more frequent than currently acknowledged. Copyright 2001 BEA Trading Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11466028     DOI: 10.1053/seiz.2000.0500

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  7 in total

1.  Down syndrome and dementia: seizures and cognitive decline.

Authors:  Ira T Lott; Eric Doran; Vinh Q Nguyen; Anne Tournay; Nina Movsesyan; Daniel L Gillen
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Neurologic complications of Down syndrome: a systematic review.

Authors:  Jonathan D Santoro; Dania Pagarkar; Duong T Chu; Mattia Rosso; Kelli C Paulsen; Pat Levitt; Michael S Rafii
Journal:  J Neurol       Date:  2020-09-12       Impact factor: 6.682

3.  Progressive myoclonus epilepsy in Down syndrome patients with dementia.

Authors:  Giuseppe d'Orsi; Luigi M Specchio
Journal:  J Neurol       Date:  2014-06-04       Impact factor: 4.849

Review 4.  Epileptic seizures in AD patients.

Authors:  A J Larner
Journal:  Neuromolecular Med       Date:  2009-06-26       Impact factor: 3.843

5.  Characterization of PTZ-induced seizure susceptibility in a down syndrome mouse model that overexpresses CSTB.

Authors:  Véronique Brault; Benoît Martin; Nathalie Costet; Jean-Charles Bizot; Yann Hérault
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

6.  Treatment of Epilepsy Associated with Common Chromosomal Developmental Diseases.

Authors:  Magdalena Budisteanu; Claudia Jurca; Sorina Mihaela Papuc; Ina Focsa; Dan Riga; Sorin Riga; Alexandru Jurca; Aurora Arghir
Journal:  Open Life Sci       Date:  2020-02-28       Impact factor: 0.938

Review 7.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.